FOLLO, MATILDE YUNG
FOLLO, MATILDE YUNG
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Docenti di ruolo di Ia fascia
M. Follo; Matilde Y. Follo; F. Matilde; MY Follo; FOLLO MY
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes
2023 Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casalin, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells.
2019 Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Libra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA.
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells.
2019 S.M. Akula, S. Candido, M. Libra, S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, G. Ramazzotti, S. Ratti, M.Y. Follo, A.M. Martelli, R.M. Murata, P.L. Rosalen, B. Bueno-Silva, S. Matias de Alencar, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, H.-L. Lin, P. Lombardi, J.A. McCubrey.
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells
2020 Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A.
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients
2012 Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Manzoli L.; Finelli C.; Cocco L.
Advances in MDS/AML and inositide signalling
2023 De Stefano A.; Marvi M.V.; Fazio A.; McCubrey J.A.; Suh P.G.; Ratti S.; Ramazzotti G.; Manzoli L.; Cocco L.; Follo M.Y.
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes
2015 Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza; Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y.
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES
2011 Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS
2013 Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients
2012 Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS
2012 Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study
2011 C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A. Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study
2010 Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients?
2020 Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C.
Cancer therapy and treatments during COVID-19 era
2020 Akula S.M.; Abrams S.L.; Steelman L.S.; Candido S.; Libra M.; Lerpiriyapong K.; Cocco L.; Ramazzotti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Blalock W.L.; Piazzi M.; Montalto G.; Cervello M.; Notarbartolo M.; Basecke J.; McCubrey J.A.
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia
2021 Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M.; Cocco L.; Follo M.Y.; Manzoli L.
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes
2016 Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sara; Barraco, Marilena; Cocco, Lucio
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE
2013 Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta M; Stanzani M; Martinelli G; Manzoli L; Cocco L; Finelli C
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide
2013 M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Manzoli; C. Cocco; C. Finelli
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q)
2013 Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani; Michele Baccarani; Lucio Cocco
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes | Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casali...n, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y | 2023-01-01 | CLINICAL EPIGENETICS | - | 1.01 Articolo in rivista | s13148-023-01441-9.pdf; 13148_2023_1441_MOESM2_ESM.pdf; 13148_2023_1441_MOESM3_ESM (1).pdf; 13148_2023_1441_MOESM1_ESM.xlsx |
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells. | Abrams SL, Follo MY, Steelman LS, Lertpiriyapong K, Cocco L, Ratti S, Martelli AM, Candido S, Lib...ra M, Murata RM, Rosalen PL, Montalto G, Cervello M, Gizak A, Rakus D, Mao W, Lombardi P, McCubrey JA. | 2019-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
Abilities of berberine and chemically modified berberines to interact with metformin and inhibit proliferation of pancreatic cancer cells. | S.M. Akula, S. Candido, M. Libra, S.L. Abrams, L.S. Steelman, K. Lertpiriyapong, G. Ramazzotti, S.... Ratti, M.Y. Follo, A.M. Martelli, R.M. Murata, P.L. Rosalen, B. Bueno-Silva, S. Matias de Alencar, G. Montalto, M. Cervello, A. Gizak, D. Rakus, W. Mao, H.-L. Lin, P. Lombardi, J.A. McCubrey. | 2019-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells | Akula S.M.; Candido S.; Abrams S.L.; Steelman L.S.; Lertpiriyapong K.; Cocco L.; Ramazzotti G.; R...atti S.; Follo M.Y.; Martelli A.M.; Murata R.M.; Rosalen P.L.; Bueno-Silva B.; Matias de Alencar S.; Falasca M.; Montalto G.; Cervello M.; Notarbartolo M.; Gizak A.; Rakus D.; Libra M.; McCubrey J.A. | 2020-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
Activation of nuclear inositide signalling pathways during erythropoietin therapy in low-risk MDS patients | Follo M.Y.; Mongiorgi S.; Clissa C.; Paolini S.; Martinelli G.; Martelli A.M.; Fioravanti G.; Man...zoli L.; Finelli C.; Cocco L. | 2012-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Advances in MDS/AML and inositide signalling | De Stefano A.; Marvi M.V.; Fazio A.; McCubrey J.A.; Suh P.G.; Ratti S.; Ramazzotti G.; Manzoli L....; Cocco L.; Follo M.Y. | 2023-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
An increased expression of PI-PLCβ1 is associated with myeloid differentiation and a longer response to azacitidine in myelodysplastic syndromes | Cocco, Lucio; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Russo, Domenico; Bosi, Costanza;... Quaranta, Marilisa; Malagola, Michele; Parisi, Sarah; Stanzani, Marta; Ramazzotti, Giulia; Mariani, Giulia A.; Billi, Anna Maria; Manzoli, Lucia; Follo, Matilde Y. | 2015-01-01 | JOURNAL OF LEUKOCYTE BIOLOGY | - | 1.01 Articolo in rivista | - |
AZACITIDINE FOR HIGH RISK MYELODYSPLASTIC SYNDROMES. RETROSPECTIVE EVALUATION OF TWO DIFFERENT DOSING SCHEDULES |
Finelli C; Clissa C; Follo MY; Curti A;Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Bosi C; ...Manzoli L; Martinelli G; Cocco L; Baccarani M |
2011-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
AZACITIDINE IN HIGH AND LOW RISK MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF 57 PATIENTS TREATED WITH 4 DIFFERENT THERAPEUTIC REGIMENS |
Clissa C;Finelli C;Follo MY; Stanzani M; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi ...S; Abbenante MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Cavo M |
2013-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Azacitidine in Myelodysplastic Syndromes: Multicenter Retrospective Study of 34 Long-Responder Patients | Carlo Finelli; Cristina Clissa; Maria Teresa Voso; Maria Antonietta Aloe Spiriti; Massimo Breccia...; Gianluca Gaidano; Monica Crugnola; Maria Benedetta Giannini; Costanza Bosi; Virginia Naso; Matilde Y Follo; Sara Mongiorgi; Giovanni Martinelli; Lucio Cocco; Michele Baccarani | 2012-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
AZACITIDINE IN MYELODYSPLASTIC SYNDROMES: RETROSPECTIVE EVALUATION OF LONG-RESPONDER PATIENTS |
Clissa C; Finelli C; Follo MY; Curti A; Paolini S; Papayannidis C; Mongiorgi S; Parisi S; Abbenan...te MC; Bosi C; Manzoli L; Martinelli G; Cocco L; Baccarani M |
2012-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Azacitidine low-dose schedule in low-risk myelodysplastic syndromes. Clinical results of a multicenter phase II study | C. Fill; C. Finelli; M. Gobbi; G. Martinelli; I. Iacobucci; E. Ottaviani; L. Cocco; F. Matilde; A.... Candoni; E. Simeone; M. Miglino; F. Lauria; M. Bocchia; M. Defina; C. Clissa; F. Lanza; P. Spedini; C. Skert; C. Bergonzi; M. Malagola; A. Peli; A. Turra; F. Cattina; C. Colombi; D. Russo | 2011-01-01 | LEUKEMIA RESEARCH | - | 4.02 Riassunto (Abstract) | - |
Azacitidine Low-Dose Schedule In Low-Risk Myelodysplastic Syndromes. Preliminary Results of a Multicenter Phase II Study | Carla Filì; Carlo Finelli; Marco Gobbi; Giovanni Martinelli; Ilaria Iacobucci; Emanuela Ottaviani...; Lucio Cocco; Matilde Y. Follo; Anna Candoni; Erika Simeone; Maurizio Miglino; Francesco Lauria; Monica Bocchia; Marzia Defina; Cristina Clissa; Francesco Lanza; Antonio Curti; Stefania Paolini; Pier Angelo Spedini; Cristina Skert; Cesare Bergonzi; Michele Malagola; Annalisa Peli; Alessandro Turra; Federica Cattina; Chiara Colombi; Domenico Russo | 2010-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients? | Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C. | 2020-01-01 | CANCERS | - | 1.01 Articolo in rivista | cancers-12-03498-v3(1).pdf |
Cancer therapy and treatments during COVID-19 era | Akula S.M.; Abrams S.L.; Steelman L.S.; Candido S.; Libra M.; Lerpiriyapong K.; Cocco L.; Ramazzo...tti G.; Ratti S.; Follo M.Y.; Martelli A.M.; Blalock W.L.; Piazzi M.; Montalto G.; Cervello M.; Notarbartolo M.; Basecke J.; McCubrey J.A. | 2020-01-01 | ADVANCES IN BIOLOGICAL REGULATION | - | 1.01 Articolo in rivista | - |
Clinical and molecular insights in erythropoiesis regulation of signal transduction pathways in myelodysplastic syndromes and β-thalassemia | Parisi S.; Finelli C.; Fazio A.; De Stefano A.; Mongiorgi S.; Ratti S.; Cappellini A.; Billi A.M....; Cocco L.; Follo M.Y.; Manzoli L. | 2021-01-01 | INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | - | 1.01 Articolo in rivista | ijms-22-00827-v2.pdf |
Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes | Finelli, Carlo; Follo, Matilde Y; Stanzani, Marta; Parisi, Sarah; Clissa, Cristina; Mongiorgi, Sa...ra; Barraco, Marilena; Cocco, Lucio | 2016-01-01 | CURRENT PHARMACEUTICAL DESIGN | - | 1.01 Articolo in rivista | - |
CLONAL ACTIVATION OF AKT IN LOW-RISK MDS PATIENTS WITH DEL(5Q) TREATED WITH LENALIDOMIDE |
Follo MY; Clissa C; Mongiorgi S; Stoyanova M; Paolini S; Quaranta M; Stanzani M; Martinelli G; Ma...nzoli L; Cocco L; Finelli C |
2013-01-01 | HAEMATOLOGICA | - | 4.01 Contributo in Atti di convegno | - |
Clonal activation of Akt in low-risk MDS patients with del(5q) treated with lenalidomide | M.Y. Follo; S. Mongiorgi; C. Clissa; M. Stoyanova; S. Paolini; M. Quaranta; G. Martinelli; L. Man...zoli; C. Cocco; C. Finelli | 2013-01-01 | LEUKEMIA RESEARCH | - | 4.01 Contributo in Atti di convegno | - |
Clonal Effect Of Lenalidomide On Akt Activation In Low-Risk MDS Patients With Del(5q) | Matilde Y Follo; Carlo Finelli; Cristina Clissa; Sara Mongiorgi; Carmen Baldazzi; Marta Stanzani;... Michele Baccarani; Lucio Cocco | 2013-01-01 | BLOOD | - | 4.01 Contributo in Atti di convegno | - |